Generoso Ianniciello M.Sc., Chief Business Officer

Generoso Ianniciello is a leader in the life sciences industry with expertise in start-ups, multi-omics, diagnostics, biopharma, and platform services. As Chief Business Officer at Anima Biotech, he drives strategies to expand the adoption of Anima’s tech.bio platform among pharmaceutical companies.

Before joining Anima, Generoso was Chief Business Officer at Dante Genomics, a leading multi-omics company. There, he played a key role in growing the start-up into a successful enterprise with over 200 employees and $100 million in annual revenue. He led the development and launch of the Dante MyGenome Platform for Longevity, Personalized Medicine, and Rare Disease Diagnostics, and established key strategic partnerships with major Hospital Chains, Biopharma companies and Key Research Institutions.

During the COVID-19 pandemic, as Senior Director of Innovation, Generoso managed the setup of large-scale labs in Italy, the UK, and Dubai, and established molecular biology labs on 90 cruise ships, conducting over 3 million RT-PCR tests.

Generoso holds an MSc in Health Biology and a BSc in Biology from the University of L’Aquila, with research experience in Molecular Biology from the University of Aberdeen in Scotland.